Park Edge Advisors’s AbbVie ABBV Stock Holding History

Park Edge Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870K	Sell	3,457 -6,125	-64%	-$1.32M	0.18%	85
2026 Q1	$2.08M	Buy	9,582 +329	+4%	+$73K	0.48%	36
2025 Q4	$2.11M	Buy	9,253 +3,394	+58%	+$773K	0.48%	44
2025 Q3	$1.36M	Buy	5,859 +2,087	+55%	+$425K	0.31%	62
2025 Q2	$700K	Hold	3,772	–	–	0.18%	81
2025 Q1	$790K	Sell	3,772 -150	-4%	-$29.2K	0.22%	75
2024 Q4	$697K	Buy	3,922 +1	+0%	+$184	0.2%	77
2024 Q3	$774K	Hold	3,921	–	–	0.22%	78
2024 Q2	$673K	Sell	3,921 -250	-6%	-$41.4K	0.21%	76
2024 Q1	$760K	Sell	4,171 -200	-5%	-$34.5K	0.21%	66
2023 Q4	$677K	Sell	4,371 -3,498	-44%	-$510K	0.23%	57
2023 Q3	$1.17M	Buy	7,869 +3,045	+63%	+$447K	0.42%	26
2023 Q2	$650K	Hold	4,824	–	–	0.22%	45
2023 Q1	$769K	Sell	4,824 -467	-9%	-$71.4K	0.3%	35
2022 Q4	$855K	Buy	+5,291	New	+$811K	0.38%	29

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Park Edge Advisors's ABBV Position: Q2 2026 in Review

Park Edge Advisors reduced its AbbVie (ABBV) stake by 64% in Q2 2026, selling an estimated $1.32M and leaving 3,457 shares worth $870K. The position accounts for 0.18% of the portfolio, ranked #85.

Park Edge Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.11M in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Park Edge Advisors held 3,457 shares of AbbVie worth $870K as of Q2 2026.
Park Edge Advisors sold 6,125 AbbVie shares in Q2 2026, an estimated $1.32M.
AbbVie made up 0.18% of Park Edge Advisors's portfolio in Q2 2026, its #85 holding.
Park Edge Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Park Edge Advisors's AbbVie position peaked at $2.11M in Q4 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Park Edge Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.